MAPT and systemic lupus erythematosus: Indeed, the cerebrospinal fluid of patients with SLE presents increased levels of neurofilament (a neuronal degradation product), Tau (an axonal degeneration product) and astroglial fibrillary acidic protein (a marker of neuronal damage and gliosis) compared to that of healthy controls [21, 22].